Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma - Aix-Marseille Université Access content directly
Journal Articles Leukemia & lymphoma Year : 2020

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma

No file

Dates and versions

hal-03159741 , version 1 (04-03-2021)

Identifiers

Cite

Vadim Ivanov, Laure Farnault, Cedric Mercier, Cecile Colavolpe, Geoffroy Venton, et al.. Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma. Leukemia & lymphoma, 2020, 61 (5), pp.1230-1233. ⟨10.1080/10428194.2019.1706737⟩. ⟨hal-03159741⟩

Collections

CNRS UNIV-AMU
17 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More